Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
- Skin care
- Wound Care
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 314343
Licensor specifically excludes from the foregoing license and reserves for itself the exclusive right to, and the right to license others to, make, have made, use, sell, have sold, or import any Cosmetic Product which contains 2-,methylene-19-nor-1a hydroxyhomopregnacalciferol. If the selected compound is 2-methylene-19-nor-1a-hydroxyhomopregnacalciferol, or 2-methylene-19-nor-bis-homo-1a hydroxypregnacalciferol, or 2-methylene-19-nor-1a hydroxypregnacalciferol, Licensor specifically excludes from the foregoing license and reserves for itself the exclusive right to, and the right to license others to, make, have made, use, sell, have sold, or import any treatment of cancer or renal osteodystrophy.
US patent #5,843,928 – 2-alkylidene-19-nor-vitamin D compounds
US patent #5,945,410 – 2-alkyl-19-nor-vitamin D compounds
Product Compound shall mean a Compound which is the active ingredient in a Product.
Cosmetic Product shall mean any product approved, made, used, sold and marketed for nonprescription cosmetic applications, which does not contain a Product Compound unless (a) such Product Compound is 2-methylene-19-nor-homopregnacalciferol, and (b) the concentration of 2-methylene-19-nor-homopregnacalciferol in the applicable product is no greater than 5 parts per million.
Compound shall mean either 2-methylene-19-nor-1a hydroxypregnacalciferol, 2-methylene-19-nor-1a hydroxyhomopregnacalciferol, or 2-methylene-19-nor-bis-homo-1a hydroxypregnacalciferol as claimed in a Licensed Patent.
Psoriasis is a chronic disease of the skin characterized by red patches covered with white scales that can occur on any part of the body.
The field of use is for topical treatments (topical treatments do not include patch delivery systems or mucous membrane delivery systems, such as a suppository, intended for systemic treatment) of skin diseases (including treatments of skin, hair and nails).
Licensee is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas including chronic skin disease.
IPSCIO Record ID: 266761
Combination Product shall mean a Product containing the Compound and at least one other active pharmaceutical ingredient.
The Compound shall mean (20S)-2-methylene-19-nor-bis-homo-1a hydroxypregnacalciferol, also referred to as becocalcidiol.
IPSCIO Record ID: 279377
Licensed Patent Rights shall mean, those portions of the patents and patent applications, and all divisions, continuations, continuations-in-part, reissues, reexaminations and extensions thereof; (a) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts for (1) the treatment of human skin wrinkles and/or fine lines on the human skin; (2) the treatment of dry skin; (3) as a skin cleanser; (4) as a hair conditioner; (5) as a shampoo; (b) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts, in combination with salicylic acid for the treatment of acne; and (c) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts in combination with two percent (2%) or less of hydroquinone for the treatment of pigmented spots on human skin.
Excluded Channel of Trade shall mean the mail order, multi-level and direct door-to-door markets. Notwithstanding the Excluded Channel of Trade herein, Licensee may process orders made by customers of Licensee as a result of 800 telephone, toll-free telephone or telephone orders, provided that Licensee and its Affiliates shall not employ television, including without limitation, television infomercials, to advertise any 800 telephone, toll-free telephone or any telephone numbers to take, process or receive sales orders.